Adamas Pharmaceuticals Inc
ADMSDelisted Nov 24, 2021- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001328143
Adamas Pharmaceuticals Inc was delisted on Nov 24, 2021; its insiders filed their last Form 4 on Nov 24, 2021; 63 institutions reported holding it in 13F filings for Q3 2021, worth $147.6M in total; no superinvestor held it.
Holders of 5% or more of ADMS
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Adamas Pharmaceuticals Inc, largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Adamas Pharmaceuticals Inc on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
13 Schedule 13D and 13G filings on Adamas Pharmaceuticals Inc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 15, 2022 | Armistice Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Stonepine Capital Management, LLC | 13G/AOld format | – | – | – | SEC |
| Jan 26, 2022 | Opaleye Management Inc. | 13G/AOld format | – | – | – | SEC |
| Dec 10, 2021 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Oct 20, 2021 | Hirschman Orin | 13G/AOld format | – | – | – | SEC |
| Oct 19, 2021 | Magnetar Financial LLC | 13DOld format | – | New | – | SEC |
| Mar 10, 2021 | FMR LLC | 13GOld format | – | New | – | SEC |
| Mar 2, 2021 | Stonepine Capital Management, LLC | 13GOld format | – | – | – | SEC |
| Feb 22, 2021 | Hirschman Orin | 13GOld format | – | New | – | SEC |
| Feb 16, 2021 | Armistice Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2021 | Opaleye Management Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2021 | Macquarie Group Ltd | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2021 | Stonepine Capital Management, LLC | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Adamas Pharmaceuticals Inc shares.
No Form 144 notices for Adamas Pharmaceuticals Inc are on file.